Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)-Reference-Cited by-同舟云学术

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

Published:2006-06 Issue:11 Volume:97 Page:1591-1596
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Blankenship James C.,Haldis Tom,Feit Frederick,Hu Tingfei,Kleiman Neal S.,Topol Eric J.,Lincoff A. Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting;Kugelmass;Am J Cardiol,1994

2. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention;Tardiff;J Am Coll Cardiol,1999

3. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices;Kini;Cath Cardiovasc Intervent,1999

4. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions;Mehran;Circulation,2000

5. Long-term clinical events following creatine-kinase myocardial band isoenzyme elevation after successful coronary stenting;Saucedo;J Am Coll Cardiol,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Challenges in Coronary Bifurcation Interventions;Medicina;2024-09-03

2. Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis;Open Heart;2022-10

3. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

4. Red Cell Distribution Width as a Marker of Periprocedural Myocardial Infarction in Patients with Elective Percutaneous Coronary Intervention;Journal of Cardiovascular Translational Research;2020-10-07

5. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia;International Journal of Cardiology;2019-12